Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)

Clinical trial NCT01651949 · COMPLETED

Trial details

NCT number: NCT01651949
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Genital Warts Anal Cancer Anal Intraepithelial Neoplasia

Start date: 2012-10-29
Primary completion: 2014-08-04
Enrollment: 2520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.